Medical weight loss is not a syringe and a slogan
These websites typically carry disclaimers clarifying that the intended use of these compounds is for research purposes, allowing their sale to wiggle through a legal loophole
Many authors discuss the inadequacy of guidelines when written based on general consensus and expert opinion, rather than on high-level clinical evidence, noting that case reports, retro/prospective studies, and observational studies, as is mostly what is currently available, are often insufficient to inform clinical practice (Australian Diabetes Society, National Association of Clinical Obesity Services, Gastroenterological Society of Australia, and Australian and New Zealand College of Anaesthetists n.d.)
Quitting it can lead to regaining much of the weight you lost
As a DTC telehealth player, you have to be involved in the market even if the GLP-1 boost functions as a short-term cash grab
Is it safe, helpful, or harmful
